{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T22:25:36Z","timestamp":1792794336116,"version":"4.5.0"},"reference-count":15,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T00:00:00Z","timestamp":1740528000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"name":"Fonds National de la Recherche Scientifique, Belgium","award":["FNRS-CDR J.0085.21"],"award-info":[{"award-number":["FNRS-CDR J.0085.21"]}]},{"DOI":"10.13039\/501100017653","name":"Fonds Sp\u00e9ciaux de Recherche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100017653","id-type":"DOI","asserted-by":"publisher"}]},{"name":"(UCLouvain)"},{"name":"Fonds de Recherche Clinique"},{"DOI":"10.13039\/501100005042","name":"Cliniques Universitaires Saint-Luc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005042","id-type":"DOI","asserted-by":"publisher"}]},{"name":"UCLouvain","id":[{"id":"https:\/\/ror.org\/02495e989","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,7,11]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Dolutegravir (DTG) treatment can lead to neuropsychiatric adverse events (NPAEs). This study assessed the association between NPAEs and polymorphisms in DTG-related pharmacogenes, determined by next-generation sequencing panel testing. Using a case-control design, 36 patients having previously discontinued DTG due to NPAEs were compared to 98 patients tolerating DTG. In the latter group, psychometric scores were compared according to genotype, targeting polymorphisms associated with drug intolerance. NR1I2 c.-22-7659C &amp;gt; T was independently associated with a reduced risk of NPAE-related DTG discontinuation (odds ratio, 0.36 [95% confidence interval, .15\u2013.88] for T-variant allele carriage) and was linked to decreased anxiety scores in control group participants.<\/jats:p>","DOI":"10.1093\/infdis\/jiaf098","type":"journal-article","created":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T15:21:30Z","timestamp":1740151290000},"page":"1425-1429","source":"Crossref","is-referenced-by-count":4,"title":["Dolutegravir and Risk of Neuropsychiatric Adverse Events: A Pharmacogenetic Study"],"prefix":"10.1093","volume":"231","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0200-1237","authenticated-orcid":false,"given":"Julien","family":"De Greef","sequence":"first","affiliation":[{"name":"Louvain Centre for Toxicology and Applied Pharmacology, Institut de Recherche Exp\u00e9rimentale et Clinique, Universit\u00e9 Catholique de Louvain (UCLouvain), Brussels ,","place":["Belgium"]},{"name":"Service de M\u00e9decine Interne et Maladies Infectieuses, HIV\/AIDS Reference Center, Cliniques universitaires Saint-Luc, Brussels ,","place":["Belgium"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean Cyr","family":"Yombi","sequence":"additional","affiliation":[{"name":"Service de M\u00e9decine Interne et Maladies Infectieuses, HIV\/AIDS Reference Center, Cliniques universitaires Saint-Luc, Brussels ,","place":["Belgium"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Vincent","sequence":"additional","affiliation":[{"name":"Service de M\u00e9decine Interne et Maladies Infectieuses, HIV\/AIDS Reference Center, Cliniques universitaires Saint-Luc, Brussels ,","place":["Belgium"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Vandercam","sequence":"additional","affiliation":[{"name":"Service de M\u00e9decine Interne et Maladies Infectieuses, HIV\/AIDS Reference Center, Cliniques universitaires Saint-Luc, Brussels ,","place":["Belgium"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"de Timary","sequence":"additional","affiliation":[{"name":"Service de Psychiatrie Adulte, Institut de Psychiatrie Int\u00e9gr\u00e9e, Cliniques universitaires Saint-Luc, Brussels ,","place":["Belgium"]},{"name":"Institute of Neuroscience, Universit\u00e9 Catholique de Louvain (UCLouvain), Brussels ,","place":["Belgium"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6390-829X","authenticated-orcid":false,"given":"Lidvine","family":"Boland","sequence":"additional","affiliation":[{"name":"Department of Clinical Chemistry, Cliniques universitaires Saint-Luc, Brussels ,","place":["Belgium"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magali","family":"Philippeau","sequence":"additional","affiliation":[{"name":"Molecular Biology Laboratory, Center for Human Genetics, Cliniques universitaires Saint-Luc, Brussels ,","place":["Belgium"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadtha","family":"Panin","sequence":"additional","affiliation":[{"name":"Louvain Centre for Toxicology and Applied Pharmacology, Institut de Recherche Exp\u00e9rimentale et Clinique, Universit\u00e9 Catholique de Louvain (UCLouvain), Brussels ,","place":["Belgium"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laure","family":"Elens","sequence":"additional","affiliation":[{"name":"Louvain Centre for Toxicology and Applied Pharmacology, Institut de Recherche Exp\u00e9rimentale et Clinique, Universit\u00e9 Catholique de Louvain (UCLouvain), Brussels ,","place":["Belgium"]},{"name":"Integrated PharmacoMetrics, PharmacoGenomics and PharmacoKinetics, Louvain Drug Research Institute, Universit\u00e9 Catholique de Louvain \u00a0 (UCLouvain), Brussels ,","place":["Belgium"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5040-9806","authenticated-orcid":false,"given":"Vincent","family":"Haufroid","sequence":"additional","affiliation":[{"name":"Louvain Centre for Toxicology and Applied Pharmacology, Institut de Recherche Exp\u00e9rimentale et Clinique, Universit\u00e9 Catholique de Louvain (UCLouvain), Brussels ,","place":["Belgium"]},{"name":"Department of Clinical Chemistry, Cliniques universitaires Saint-Luc, Brussels ,","place":["Belgium"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1701-7584","authenticated-orcid":false,"given":"Le\u00efla","family":"Belkhir","sequence":"additional","affiliation":[{"name":"Louvain Centre for Toxicology and Applied Pharmacology, Institut de Recherche Exp\u00e9rimentale et Clinique, Universit\u00e9 Catholique de Louvain (UCLouvain), Brussels ,","place":["Belgium"]},{"name":"Service de M\u00e9decine Interne et Maladies Infectieuses, HIV\/AIDS Reference Center, Cliniques universitaires Saint-Luc, Brussels ,","place":["Belgium"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,2,26]]},"reference":[{"key":"2025071111123473600_jiaf098-B1","author":"Hoffman"},{"key":"2025071111123473600_jiaf098-B2","doi-asserted-by":"crossref","first-page":"3110","DOI":"10.1093\/jac\/dkac290","article-title":"Pharmacokinetic and pharmacogenetic associations with dolutegravir neuropsychiatric adverse events in an African population","volume":"77","author":"Griesel","year":"2022","journal-title":"J Antimicrob Chemother"},{"key":"2025071111123473600_jiaf098-B3","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1186\/s12879-017-2717-x","article-title":"Impact of UGT1A1 gene polymorphisms on plasma dolutegravir trough concentrations and neuropsychiatric adverse events in Japanese individuals infected with HIV-1","volume":"17","author":"Yagura","year":"2017","journal-title":"BMC Infect Dis"},{"key":"2025071111123473600_jiaf098-B4","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1093\/cid\/ciy426","article-title":"Increased dolutegravir peak concentrations in people living with human immunodeficiency virus aged 60 and over, and analysis of sleep quality and cognition","volume":"68","author":"Elliot","year":"2019","journal-title":"Clin Infect Dis"},{"key":"2025071111123473600_jiaf098-B5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brainres.2012.10.060","article-title":"Pregnane X receptor upregulates ABC-transporter Abcg2 and Abcb1 at the blood-brain barrier","volume":"1491","author":"Lemmen","year":"2013","journal-title":"Brain Res"},{"key":"2025071111123473600_jiaf098-B6","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1093\/jac\/dky508","article-title":"SLC22A2 variants and dolutegravir levels correlate with psychiatric symptoms in persons with HIV","volume":"74","author":"Borghetti","year":"2018","journal-title":"J Antimicrob Chemother"},{"key":"2025071111123473600_jiaf098-B7","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1080\/14622416.2024.2441104","article-title":"Genetic variation on dolutegravir pharmacokinetics and relation to safety and efficacy outcomes: a systematic review","volume":"25","author":"Bevers","year":"2024","journal-title":"Pharmacogenomics"},{"key":"2025071111123473600_jiaf098-B8","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1124\/dmd.107.016600","article-title":"Novel single nucleotide polymorphisms in the promoter and intron 1 of human pregnane X receptor\/NR1I2 and their association with CYP3A4 expression","volume":"36","author":"Lamba","year":"2008","journal-title":"Drug Metab Dispos"},{"key":"2025071111123473600_jiaf098-B9","doi-asserted-by":"crossref","first-page":"5242","DOI":"10.1128\/AAC.00781-10","article-title":"Population pharmacokinetic modeling of the association between 63396C-&gt;T pregnane X receptor polymorphism and unboosted atazanavir clearance","volume":"54","author":"Schipani","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"2025071111123473600_jiaf098-B10","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1007\/s40262-015-0360-5","article-title":"Comprehensive pharmacokinetic, pharmacodynamic and pharmacogenetic evaluation of once-daily efavirenz 400 and 600\u2005mg in treatment-na\u00efve HIV-infected patients at 96 weeks: results of the ENCORE1 study","volume":"55","author":"Dickinson","year":"2016","journal-title":"Clin Pharmacokinet"},{"key":"2025071111123473600_jiaf098-B11","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1093\/jac\/dkz558","article-title":"Genetic influence of ABCG2, UGT1A1 and NR1I2 on dolutegravir plasma pharmacokinetics","volume":"75","author":"Elliot","year":"2020","journal-title":"J Antimicrob Chemother"},{"key":"2025071111123473600_jiaf098-B12","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1093\/infdis\/jiac174","article-title":"Pharmacogenetics of dolutegravir plasma exposure among Southern Africans living with HIV","volume":"226","author":"Cindi","year":"2022","journal-title":"J Infect Dis"},{"key":"2025071111123473600_jiaf098-B13","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.bcp.2018.10.012","article-title":"CYP1A1 and 1B1-mediated metabolic pathways of dolutegravir, an HIV integrase inhibitor","volume":"158","author":"Zhu","year":"2018","journal-title":"Biochem Pharmacol"},{"key":"2025071111123473600_jiaf098-B14","doi-asserted-by":"crossref","first-page":"2666","DOI":"10.1111\/bph.15055","article-title":"The constitutive androstane receptor and pregnane X receptor in the brain","volume":"177","author":"Torres-Vergara","year":"2020","journal-title":"Br J Pharmacol"},{"key":"2025071111123473600_jiaf098-B15","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.neuroscience.2017.07.038","article-title":"Pregnane X receptor deletion modifies recognition memory and electroencephalographic activity","volume":"370","author":"Boussadia","year":"2018","journal-title":"Neuroscience"}],"container-title":["The Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jid\/advance-article-pdf\/doi\/10.1093\/infdis\/jiaf098\/62172048\/jiaf098.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jid\/article-pdf\/231\/6\/1425\/62172048\/jiaf098.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jid\/article-pdf\/231\/6\/1425\/62172048\/jiaf098.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,11]],"date-time":"2025-07-11T15:12:40Z","timestamp":1752246760000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jid\/article\/231\/6\/1425\/8042716"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,26]]},"references-count":15,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025,2,26]]},"published-print":{"date-parts":[[2025,7,11]]}},"URL":"https:\/\/doi.org\/10.1093\/infdis\/jiaf098","relation":{},"ISSN":["0022-1899","1537-6613"],"issn-type":[{"value":"0022-1899","type":"print"},{"value":"1537-6613","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,6,15]]},"published":{"date-parts":[[2025,2,26]]}}}